Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Michael Ryskin is an analyst at B of A Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/01/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
03/03/2025 | MRVI | Buy Now | Maravai LifeSciences | $2.00 | 300% | Michael Ryskin44% | $9 → $8 | Maintains | Buy | Get Alert |
03/03/2025 | TEM | Buy Now | Tempus AI | $52.50 | 14.29% | Michael Ryskin44% | $54 → $60 | Maintains | Neutral | Get Alert |
02/04/2025 | IDXX | Buy Now | IDEXX Laboratories | $470.77 | 13.64% | Michael Ryskin44% | $475 → $535 | Maintains | Neutral | Get Alert |
12/13/2024 | TEM | Buy Now | Tempus AI | $52.50 | 2.86% | Michael Ryskin44% | $52 → $54 | Maintains | Neutral | Get Alert |
12/13/2024 | ALGN | Buy Now | Align Tech | $177.81 | 15.85% | Michael Ryskin44% | $200 → $206 | Maintains | Underperform | Get Alert |
10/02/2024 | TEM | Buy Now | Tempus AI | $52.50 | 14.29% | Michael Ryskin44% | $45 → $60 | Downgrade | Buy → Neutral | Get Alert |
07/18/2024 | GH | Buy Now | Guardant Health | $48.15 | -16.93% | Michael Ryskin44% | $28 → $40 | Maintains | Buy | Get Alert |
07/09/2024 | TEM | Buy Now | Tempus AI | $52.50 | -21.9% | Michael Ryskin44% | → $41 | Initiates | → Buy | Get Alert |
06/25/2024 | ALIT | Buy Now | Alight | $5.16 | 84.11% | Michael Ryskin44% | $10 → $9.5 | Maintains | Buy | Get Alert |
01/05/2024 | EXAI | Buy Now | Exscientia | — | — | Michael Ryskin44% | $11 → $9 | Downgrade | Buy → Neutral | Get Alert |
12/12/2023 | MRVI | Buy Now | Maravai LifeSciences | $2.00 | 300% | Michael Ryskin44% | $10 → $8 | Upgrade | Neutral → Buy | Get Alert |
08/15/2023 | CERT | Buy Now | Certara | $13.26 | 81% | Michael Ryskin44% | $27 → $24 | Maintains | Buy | Get Alert |
07/31/2023 | AVTR | Buy Now | Avantor | $12.93 | 85.69% | Michael Ryskin44% | $27 → $24 | Maintains | Buy | Get Alert |
06/16/2023 | ABCM | Buy Now | Abcam | — | — | Michael Ryskin44% | → $25 | Upgrade | Neutral → Buy | Get Alert |
04/30/2023 | AVTR | Buy Now | Avantor | $12.93 | 108.9% | Michael Ryskin44% | $30 → $27 | Maintains | Buy | Get Alert |
04/27/2023 | ALGN | Buy Now | Align Tech | $177.81 | 26.54% | Michael Ryskin44% | $190 → $225 | Maintains | Underperform | Get Alert |
11/04/2022 | ZTS | Buy Now | Zoetis | $156.19 | 15.25% | Michael Ryskin44% | $225 → $180 | Maintains | Buy | Get Alert |
11/03/2022 | MRVI | Buy Now | Maravai LifeSciences | $2.00 | 750% | Michael Ryskin44% | $32 → $17 | Downgrade | Buy → Neutral | Get Alert |
10/17/2022 | ALGN | Buy Now | Align Tech | $177.81 | 12.48% | Michael Ryskin44% | $235 → $200 | Maintains | Underperform | Get Alert |
08/10/2022 | OMIC | Buy Now | Singular Genomics Sys | — | — | Michael Ryskin44% | → $90 | Downgrade | Buy → Underperform | Get Alert |
07/28/2022 | ALGN | Buy Now | Align Tech | $177.81 | 32.16% | Michael Ryskin44% | $260 → $235 | Maintains | Underperform | Get Alert |
05/05/2022 | IDXX | Buy Now | IDEXX Laboratories | $470.77 | -0.16% | Michael Ryskin44% | $550 → $470 | Downgrade | Buy → Neutral | Get Alert |
04/18/2022 | RXRX | Buy Now | Recursion Pharmaceuticals | $5.55 | — | Michael Ryskin44% | — | Downgrade | Buy → Neutral | Get Alert |
02/16/2022 | ZTS | Buy Now | Zoetis | $156.19 | 62.63% | Michael Ryskin44% | $258 → $254 | Maintains | Buy | Get Alert |
02/03/2022 | ALGN | Buy Now | Align Tech | $177.81 | 181.19% | Michael Ryskin44% | $550 → $500 | Maintains | Underperform | Get Alert |
01/07/2022 | OMIC | Buy Now | Singular Genomics Sys | — | — | Michael Ryskin44% | → $630 | Upgrade | Neutral → Buy | Get Alert |
11/11/2021 | SDGR | Buy Now | Schrodinger | $25.25 | 105.94% | Michael Ryskin44% | $80 → $52 | Downgrade | Buy → Neutral | Get Alert |
11/10/2021 | ABSI | Buy Now | Absci | $3.00 | 233.05% | Michael Ryskin44% | $17 → $10 | Downgrade | Neutral → Underperform | Get Alert |
10/27/2021 | ZTS | Buy Now | Zoetis | $156.19 | 44.06% | Michael Ryskin44% | $225 → $225 | Maintains | Buy | Get Alert |
10/26/2021 | EXAI | Buy Now | Exscientia | — | — | Michael Ryskin44% | → $27 | Initiates | → Buy | Get Alert |
08/16/2021 | ABSI | Buy Now | Absci | $3.00 | 765.94% | Michael Ryskin44% | → $26 | Initiates | → Neutral | Get Alert |
07/27/2021 | ZTS | Buy Now | Zoetis | $156.19 | 44.06% | Michael Ryskin44% | → $225 | Maintains | Buy | Get Alert |
06/21/2021 | OMIC | Buy Now | Singular Genomics Sys | — | — | Michael Ryskin44% | → $780 | Initiates | → Neutral | Get Alert |
05/11/2021 | RXRX | Buy Now | Recursion Pharmaceuticals | $5.55 | 458.06% | Michael Ryskin44% | → $31 | Initiates | → Buy | Get Alert |
03/08/2021 | ZTS | Buy Now | Zoetis | $156.19 | 15.25% | Michael Ryskin44% | → $180 | Upgrade | Neutral → Buy | Get Alert |
01/05/2021 | CERT | Buy Now | Certara | $13.26 | 209.2% | Michael Ryskin44% | → $41 | Initiates | → Buy | Get Alert |
11/23/2020 | SDGR | Buy Now | Schrodinger | $25.25 | 193.07% | Michael Ryskin44% | → $74 | Upgrade | Neutral → Buy | Get Alert |
11/16/2020 | ABCM | Buy Now | Abcam | — | — | Michael Ryskin44% | → $20 | Initiates | → Neutral | Get Alert |
07/20/2020 | ZTS | Buy Now | Zoetis | $156.19 | -3.96% | Michael Ryskin44% | $135 → $150 | Maintains | Neutral | Get Alert |
07/20/2020 | ALGN | Buy Now | Align Tech | $177.81 | 57.47% | Michael Ryskin44% | → $280 | Downgrade | Neutral → Underperform | Get Alert |
05/14/2020 | SDC | Buy Now | SmileDirectClub | — | — | Michael Ryskin44% | $10 → $7 | Downgrade | Buy → Underperform | Get Alert |
02/26/2020 | SDC | Buy Now | SmileDirectClub | — | — | Michael Ryskin44% | $19 → $12 | Maintains | Buy | Get Alert |
02/12/2020 | ZTS | Buy Now | Zoetis | $156.19 | -7.16% | Michael Ryskin44% | $138 → $145 | Maintains | Neutral | Get Alert |